Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Natural Beauty Bio-TechnologyNBBTF -0.01%41 EBITDA Margin % is 2.26% as of Dec. 2025, which is 84% below its 10-year median of 13.73. GuruFocus rates NBBTF with a GF Score™ of 41/100 and a GF Value™ of $0.11 (Significantly Undervalued). The stock has 5 warning signs investors should review. Among 1,955 Consumer Packaged Goods companies, Natural Beauty Bio-Technology ranks worse than 71.2% on this metric.
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
Natural Beauty Bio-Technology EBITDA Margin % Related Terms
Natural Beauty Bio-Technology EBITDA Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Household & Personal Products subindustry, Natural Beauty Bio-Technology's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Natural Beauty Bio-Technology EBITDA Margin % vs Consumer Packaged Goods Industry
For the Consumer Packaged Goods industry and Consumer Defensive sector, Natural Beauty Bio-Technology's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where Natural Beauty Bio-Technology's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Natural Beauty Bio-Technology (NBBTF) has a EBITDA Margin % of 2.26% as of Dec. 2025. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Natural Beauty Bio-Technology and its competitors. This is 84% below median its historical median of 13.73. According to the industry distribution chart, Natural Beauty Bio-Technology ranks #1392 out of 1955 companies in the Consumer Packaged Goods industry, placing it in the top 71.2%.
Is Natural Beauty Bio-Technology's EBITDA Margin % too high?
Natural Beauty Bio-Technology's current EBITDA Margin % of 2.26% is 84% below median its 10-year median of 13.73. The Consumer Packaged Goods industry median EBITDA Margin % is 9.01. Natural Beauty Bio-Technology's value of 2.26% is 74.9% below this industry median. Based on the distribution chart, Natural Beauty Bio-Technology ranks #1392 out of 1955 companies in the Consumer Packaged Goods industry, which is below the industry midpoint. Overall, Natural Beauty Bio-Technology has a GF Score™ of 41/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Natural Beauty Bio-Technology's EBITDA Margin % compare to PG and CL?
According to the Consumer Packaged Goods industry distribution chart, Natural Beauty Bio-Technology ranks #1392 out of 1955 companies for EBITDA Margin %. This places Natural Beauty Bio-Technology in the lower half of its industry. The industry median EBITDA Margin % is 9.01. Natural Beauty Bio-Technology's value of 2.26% is 74.9% below this benchmark. While the company's 10-year median is 13.73 vs. the industry median of 9.01, Natural Beauty Bio-Technology has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Consumer Packaged Goods company?
The median EBITDA Margin % among Consumer Packaged Goods companies is 9.01, based on 1,955 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Natural Beauty Bio-Technology's current EBITDA Margin % of 2.26% is 74.9% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Natural Beauty Bio-Technology and its competitors. For the Consumer Packaged Goods industry, the median EBITDA Margin % is 9.01 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Natural Beauty Bio-Technology's current EBITDA Margin % is 2.26%, which is 84% below median its own 10-year median of 13.73. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Natural Beauty Bio-Technology stock overvalued right now?
Based on GuruFocus' analysis, Natural Beauty Bio-Technology (NBBTF) is currently considered Significantly Undervalued. The stock's GF Value™ is $0.11, compared to a current price of $0.06 — trading 44.4% below its estimated fair value. The current EBITDA Margin % is 2.26%, which is 84% below median its 10-year median of 13.73 and 74.9% below the Consumer Packaged Goods industry median of 9.01. Natural Beauty Bio-Technology's overall GF Score™ is 41/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Natural Beauty Bio-Technology (NBBTF), the current EBITDA Margin % is 2.26% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Natural Beauty Bio-Technology (NBBTF) Overvalued in 2026?
Based on GuruFocus' analysis, Natural Beauty Bio-Technology stock appears to be undervalued.
The current stock price of $0.06 is trading 44.4% below its estimated GF Value™ of $0.11.
GuruFocus considers Natural Beauty Bio-Technology to be Significantly Undervalued.
Key valuation signals for NBBTF:
EBITDA Margin %: 2.26% (84% below median its 10-year median of 13.73)
GF Value™: $0.11 vs. price of $0.06 (44.4% below fair value)
Industry Position: 74.9% below the Consumer Packaged Goods median (#1392 of 1955)
No single metric tells the full story. See the NBBTF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Natural Beauty Bio-Technology Business Description
Natural Beauty Bio-Technology Ltd operates as an investment holding company. It is engaged in the manufacturing and selling of skincare, beauty, and aromatherapeutic products. Its products include the provision of skin treatments, beauty and spa services, and skincare consulting and beauty training services. The company's spas provide various services, including hydrotherapy, facial treatment, body care, and skincare analysis. The company derived its key revenue from franchised spas, self-owned spas, and concessionary counters at department stores. Geographically, it has three segments, which include the PRC, Taiwan, and Others (Hong Kong and Malaysia). Its key revenue is generated from the PRC.
41GF Score
Get the complete analysis for NBBTF
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NBBTF has been successfully added to your 
